Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > January 2005

« Previous month Next month »

Genencor/Danisco tie the knot

31-Jan-2005 - The long-standing relationship between biotechnology company Genencor and Danish ingredients firm Danisco is to be cemented via the merger of the two companies.

Lanxess debuts on Frankfurt exchange

31-Jan-2005 - Lanxess, the chemicals and polymers spin-out of Germany's Bayer, made its debut on the Frankfurt stock exchange this morning.

Acatris launches directly compressible SoyLife

31-Jan-2005 - Health ingredients firm Acatris has developed a directly compressible version of its SoyLife brand soy isoflavone ingredient, designed to remove some of the hurdles for companies looking to offer isoflavone...

UK backs bioprocessing with £3m grant

31-Jan-2005 - The UK government has given the national biotechnology industry trade group £3 million (€4.3m) in funding to support the development of bioprocessing, continuing a string of projects aimed at boosting...

Merck trims down again with electronic unit sale

31-Jan-2005 - Merck KGaA is planning to sell its electronic chemicals business to BASF for €270 million, freeing it up to focus on its pharmaceutical, chemical and liquid crystal businesses.

Neuro3d initiates depression trials with ND7001

28-Jan-2005 - A new type of antidepressant drug with a novel mechanism of action, which acts on a new target, has entered Phase I clinical trials. The drug could represent a new...

Diabetes drug progress promising but slow

28-Jan-2005 - A new potential diabetes drug from Dia-B Tech, which is based on a naturally occurring peptide consisting of four amino acids, promises convenience and fewer side effects over current day...

Neich acquires Orbus Medical Tech

27-Jan-2005 - Neich Medical has acquired Orbus Medical Technologies in which Orbus is leading Neich's research and development efforts for drug eluting stents and other advanced technologies.

Chemical imaging investigated for process monitoring

27-Jan-2005 - The use of chemical imaging as a quality control measure for mixtures of pharmaceutical ingredients before tabletting has taken a step forward with the first deployment of a prototype system...

Bayer plans inhaled Cipro for cystic fibrosis

27-Jan-2005 - Bayer is to collaborate with Nektar on the development of an inhaled formulation of Cipro (ciprofloxacin) for treating the common genetic disorder cystic fibrosis.

Lonza still under pressure in 2004

27-Jan-2005 - Swiss chemicals and contract manufacturing concern Lonza reported a decline in sales but net profit up by more than half in 2004, although earnings came in at the low end...

DNT, Dow & Starpharma in 3-way dendrimer deal

27-Jan-2005 - A unique three-way-deal between Dendritic Nanotechnologies (DNT), The Dow Chemical Company and Starpharma Holdings, will provide DNT and Starpharma with access to dendrimers and nanotechnology for drug delivery.

Pall expands again in chromatography

26-Jan-2005 - Filtration and separation company Pall has made another acquisition in the chromatography sector with the purchase of Euroflow (UK) for an undisclosed amount.

UK National Biomanufacturing Centre on track for '06 start-up

26-Jan-2005 - Construction of the UK National Biomanufacturing Centre, an ambitious project aimed at helping biotechnology start-ups get their product ideas into clinical trials, is progressing on schedule and should be ready...

Transgenic specialist Pharming raises €7m

26-Jan-2005 - Pharming of the Netherlands, which is pioneering the use of transgenic animals for the production of biologics, has raised €7 million in new funding and will use the proceeds to...

Dow spins out dendrimer portfolio to nanotech firm

26-Jan-2005 - Dow Chemical has signed over its entire portfolio of intellectual property and technology in the area of dendrimers - branched polymers with applications in targetted drug delivery - to US...

New active agents against leishmaniasis

26-Jan-2005 - Scientists have targeted the alkaloids of the quinolines chemical family, which have proved effective against visceral leishmaniasis treating this severe form of the disease with its antiparasitic properties.

Cargill to buy out plastics business

25-Jan-2005 - Cargill says it has agreed to acquire The Dow Chemical Company's interest in Cargill Dow LLC, the 50/50 joint venture formed in 1997 to commercialise polylactic acid biopolymers.

Nanotech could be answer to gene therapy delivery

25-Jan-2005 - Researchers in the US have shown that nanoparticles can be used to deliver genetic material into cells safely and effectively, potentially overcoming the primary obstacle to the development of gene...

ALFRED speeds up process R&D at Degussa

25-Jan-2005 - Specialty chemicals company Degussa has developed an put in place an automated workstation that should speed up process development and scale-up projects for its clients.

NIR, Raman set to drive process spectroscopy market

25-Jan-2005 - The global market for spectroscopic equipment used in process monitoring is tipped to grow by 30 per cent between now and 2009, helped by an increasing focus on process analytical...

MIP taking separation tech to commercial scale

25-Jan-2005 - MIP Technologies, a Swedish firm specialising in polymers with binding properties, has signed a deal which could take its technology out of the laboratory sector and into the realms of...

DNA 'glue' improves polymer drug delivery system

24-Jan-2005 - US researchers have developed a faster, more efficient way to produce a wide variety of nanoparticle-based drug delivery systems, using DNA molecules to bind the particles together.

REACH debated ahead of Parliamentary reading

24-Jan-2005 - The European Parliament embarked on a new round of deliberations over the controversial REACH legislation last week, amid intense lobbying by groups representing the chemicals industry, animal rights activists and...

Allos Therapeutics initiates new cancer therapy

24-Jan-2005 - Allos Theraputics have initiated a phase 1 study of its investigational drug PDX (pralatrexate) that has so far proved effective against non-small cell lung cancer (NSCLC). This treatment has the...

« Previous month Next month »

Key Industry Events


Access all events listing

Our events, Shows & Conferences...